Somewhat Favorable Press Coverage Somewhat Unlikely to Impact CTI BioPharma (CTIC) Share Price


Press coverage about CTI BioPharma has trended somewhat positive on Sunday, Accern reports. The research group scores the sentiment of press coverage by analyzing more than 20 million blog and news sources in real-time.



from Biotech News